Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 012928
Company: LILLY
Company: LILLY
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NOVRAD | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS | EQ 50MG BASE/5ML | SUSPENSION;ORAL | Discontinued | None | No | No |
NOVRAD | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS | EQ 100MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
NOVRAD | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS | EQ 50MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |